Dr Manuprasad

123 posts

Dr Manuprasad

@drmanuprasad

Medical Oncologist, Kerala Tweets Personal

Katılım Mayıs 2010

336 Takip Edilen241 Takipçiler

Dr Manuprasad retweetledi

kothari rushabh@rushabh1388·6 Haz

1/n It is a dream of any medical oncologist to present at the podium at ASCO. I had that dream realised today to present the first multicentric investigator initiated trial from India.@CRSF_IN @DrVijayPatil11 @shrirangwar @oncologician @drmanuprasad @ASCO #ASCO23

English

174

13.7K

Dr Manuprasad@drmanuprasad·5 Haz

@jtgeorgy @DrNikitaMehra @ASCO @ConquerCancerFd Congratulations 👏

English

Josh Thomas Georgy@jtgeorgy·4 Haz

Honored to be a part of this amazing group of oncologists from all over the world. Humbled to receive the @ASCO @ConquerCancerFd #IDEA award at Chicago. #ASCO2023

Chicago, IL 🇺🇸 English

6.6K

Dr Manuprasad retweetledi

Dr (Prof). Vijay Patil@DrVijayPatil11·31 Oca

ascopubs.org/doi/abs/10.120…. Phase 3 Docetaxel in Cisplatin unfit - is the most talked study. Email from @JCO_ASCO says so. Thank you everyone for the appreciation. @Nandinimenon18 @VanitaNoronha @drakhilkapoor1 @AnujkumarTvm @anuja_abhyankar @drmanuprasad @SewantiLimaye @HHKhar

English

1.8K

Dr Manuprasad@drmanuprasad·28 Oca

@DrVijayPatil11 @VanitaNoronha @Amolpatel_dr @Nandinimenon18 @DrEzraCohen @JCO_ASCO @HHKhar @TataMemorial @DrHaddadRobert Congratulations Sir 👏

English

120

Dr (Prof). Vijay Patil@DrVijayPatil11·28 Oca

Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. @VanitaNoronha @Amolpatel_dr @Nandinimenon18 @DrEzraCohen @JCO_ASCO @HHKhar @TataMemorial @DrHaddadRobert ascopubs.org/doi/abs/10.120…

English

144

291

62.2K

Dr Manuprasad@drmanuprasad·7 Ara

@DrNikitaMehra @dr_pkj @KrupaShankarS3 @pkshenoy Thanks Nikita ! The debate between you and Krupasankar @KrupaShankarS3 🤣

English

Nikita Mehra@DrNikitaMehra·7 Ara

The A L’Re😅 batchmates @dr_pkj @KrupaShankarS3 @pkshenoy #Shoufeej & I congratulate @drmanuprasad for this prestigious #ESMOAsia22 Award! Those arguments & fights over critical appraisals of journals & the debates followed by clandestine rebuttals have taken meaning today!

Dr Manuprasad@drmanuprasad

Thank you very much @myESMO for an excellent academic feast at ESMO asia ,Merit Travel grant and for the best poster award under Genitourinary -Prostate cancer category #ESMOAsia2022

Chennai, India 🇮🇳 English

Dr Manuprasad@drmanuprasad·7 Ara

@saadvikdr @myESMO Thanks Dr Saadvik

English

Dr. Saadvik Raghuram y@saadvikdr·7 Ara

@drmanuprasad @myESMO Congratulations...

English

Dr Manuprasad@drmanuprasad·4 Ara

Thank you very much @myESMO for an excellent academic feast at ESMO asia ,Merit Travel grant and for the best poster award under Genitourinary -Prostate cancer category #ESMOAsia2022

English

Dr Manuprasad@drmanuprasad·7 Ara

@suhaildrdeen @myESMO Thank you !

English

Suhail Deen@suhaildrdeen·7 Ara

@drmanuprasad @myESMO Congratulations 👏👏

English

Dr Manuprasad@drmanuprasad·7 Ara

@oncologician @myESMO Thank you 😊

English

Nirmal Raut@oncologician·6 Ara

@drmanuprasad @myESMO Congratulations @drmanuprasad !!!

English

Dr Manuprasad@drmanuprasad·6 Ara

@VanitaNoronha Thank you madam!

English

Vanita Noronha, MBBS MD DM@VanitaNoronha·6 Ara

Congrats!

Dr Manuprasad@drmanuprasad

Thank you very much @myESMO for an excellent academic feast at ESMO asia ,Merit Travel grant and for the best poster award under Genitourinary -Prostate cancer category #ESMOAsia2022

English